Teladoc (TDOC) CAO exercises stock units and sells shares for taxes

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Teladoc Health Chief Accounting Officer Joseph Ronald Catapano reported routine equity compensation activity. On June 1, 2026, he exercised restricted stock units and performance stock units that converted into a total of 872 shares of common stock at $0.00 per share. On June 2, 2026, 284 shares of common stock were sold at $7.627 per share to cover tax withholding obligations related to these vestings. After these transactions, he directly holds 10,837 shares of Teladoc Health common stock.

Insider Trade Summary

Net Seller: 284 shares ($2,166)

Net Sell 5 txns

Insider Catapano Joseph Ronald

Role Chief Accounting Officer

Sold 284 shs ($2K)

Type	Security	Shares	Price	Value
Sale	Common Stock	284	$7.627	$2K
Exercise	Performance Stock Units	39	$0.00	--
Exercise	Restricted Stock Units	833	$0.00	--
Exercise	Common Stock	39	$0.00	--
Exercise	Common Stock	833	$0.00	--

Holdings After Transaction: Common Stock — 10,837 shares (Direct, null); Performance Stock Units — 271 shares (Direct, null); Restricted Stock Units — 5,834 shares (Direct, null)

Footnotes (1)

Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

Shares sold: 284 shares Sale price: $7.627 per share Shares from equity award exercises: 872 shares +3 more

6 metrics

Shares sold 284 shares Common stock sold on June 2, 2026 at $7.627 per share

Sale price $7.627 per share Price for 284 Teladoc common shares sold to cover taxes

Shares from equity award exercises 872 shares Common shares received from exercising RSUs and PSUs on June 1, 2026

Post-transaction holdings 10,837 shares Direct Teladoc common stock held after reported transactions

Performance stock units earned 465 units Earned on March 1, 2026, vesting over time

Restricted stock units granted 10,000 units Granted on March 1, 2025, vesting over time

Key Terms

Performance stock units, Restricted stock units, tax withholding obligation, derivative exercise/conversion

4 terms

Performance stock units financial

"Performance stock units convert to shares of TDOC common stock on a one-for-one basis."

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Restricted stock units financial

"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligation financial

"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards."

derivative exercise/conversion financial

"transaction_action: derivative exercise/conversion"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/03/2026 - 04:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Catapano Joseph Ronald

(Last)

(First)

(Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/01/2026		M		39	A	⁽¹⁾	10,288	D
Common Stock	06/01/2026		M		833	A	⁽²⁾	11,121	D
Common Stock	06/02/2026		S		284⁽³⁾	D	$7.627	10,837	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Stock Units	⁽¹⁾	06/01/2026		M			39	⁽⁴⁾	⁽⁴⁾	Common Stock	39	$0	271	D
Restricted Stock Units	⁽²⁾	06/01/2026		M			833	⁽⁵⁾	⁽⁵⁾	Common Stock	833	$0	5,834	D

Explanation of Responses:

1. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

2. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

4. On March 1, 2026, the reporting person earned 465 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

5. On March 1, 2025, the reporting person was granted 10,000 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Teladoc (TDOC) report for Joseph Ronald Catapano?

Teladoc reported that Chief Accounting Officer Joseph Ronald Catapano exercised equity awards into 872 common shares and sold 284 shares. The sale was made to cover tax withholding obligations tied to vesting performance and restricted stock units.

How many Teladoc (TDOC) shares did the CAO sell and at what price?

Joseph Ronald Catapano reported selling 284 shares of Teladoc common stock at $7.627 per share. According to the filing footnote, these shares were sold specifically to satisfy tax withholding obligations from recently vested stock awards.

Were Teladoc (TDOC) insider sales by Joseph Catapano part of tax withholding?

Yes. The filing states that the 284 Teladoc shares sold by Joseph Ronald Catapano were used to cover tax withholding obligations arising from the vesting of his performance stock unit and restricted stock unit awards.

How many Teladoc (TDOC) shares does Joseph Ronald Catapano hold after these transactions?

Following the reported transactions, Joseph Ronald Catapano directly holds 10,837 shares of Teladoc Health common stock. This reflects his position after exercising stock-based awards and selling a portion of shares to cover related tax obligations.

What equity awards did Teladoc (TDOC) grant or earn for Joseph Catapano mentioned in this filing?

The filing notes he earned 465 performance stock units on March 1, 2026 and was granted 10,000 restricted stock units on March 1, 2025. Both awards vest over time in quarterly installments after an initial one-third vesting tranche.

How do Teladoc (TDOC) performance and restricted stock units convert into common shares?

According to the footnotes, both performance stock units and restricted stock units for Teladoc Health convert into common stock on a one-for-one basis. Each vested unit therefore delivers one share of Teladoc common stock to the reporting person.